Search Count: 41
 |
Human Jak3 Kinase Domain With 1-(4-((2-((1-Methyl-1H-Pyrazol-4-Yl)Amino)Quinazolin-8-Yl)Amino)Piperidin-1-Yl)Ethan-1-One
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.75 Å Release Date: 2022-02-02 Classification: SIGNALING PROTEIN Ligands: 934, SO4, PHU |
 |
Jak2 In Complex With 4-{8-Methoxy-2-[(1-Methyl-1H-Pyrazol-4-Yl)Amino]Quinazolin-6-Yl}Phenol
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.78 Å Release Date: 2022-02-02 Classification: SIGNALING PROTEIN Ligands: 9I8 |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.61 Å Release Date: 2022-02-02 Classification: SIGNALING PROTEIN Ligands: 9I5 |
 |
Jak2 In Complex With 4-(2-Amino-8-{[(2S)-1-Hydroxypropan-2-Yl]Amino}Quinazolin-6-Yl)-5-Ethyl-2-Fluorophenol
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.97 Å Release Date: 2022-02-02 Classification: SIGNALING PROTEIN Ligands: 9I2, GOL |
 |
Jak2 In Complex With 4-(2-{[5-(Dimethylamino)Pentyl]Amino}-8-{[(2S)-1-Hydroxypropan-2-Yl]Amino}Quinazolin-6-Yl)-5-Ethyl-2-Fluorophenol
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.85 Å Release Date: 2022-02-02 Classification: SIGNALING PROTEIN Ligands: 9HR |
 |
C-Terminal Bromodomain Of Human Brd2 With N-Methyl-4-Propionyl-1H-Pyrrole-2-Carboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.65 Å Release Date: 2021-07-28 Classification: NUCLEAR PROTEIN Ligands: EDO, PE4, V9B |
 |
C-Terminal Bromodomain Of Human Brd2 With N5-Hydroxycyclohexyl-N3-Methyl-1-Phenylethyl-1H-Pyrazole-3,5-Dicarboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2021-07-28 Classification: NUCLEAR PROTEIN Ligands: V9H, EDO |
 |
C-Terminal Bromodomain Of Human Brd2 With N4-Hydroxycyclohexyl-N2-Methyl-5-Phenylethyl-Furan-2,4-Dicarboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.76 Å Release Date: 2021-07-28 Classification: NUCLEAR PROTEIN Ligands: V9K, EDO |
 |
C-Terminal Bromodomain Of Human Brd2 With N5-((1R,5S,6R)-3-Oxabicyclo[3.1.0]Hexan-6-Yl)-3-(1H-Indol-4-Yl)-N7-Methyl-2,3-Dihydrobenzofuran-5,7-Dicarboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.30 Å Release Date: 2021-07-28 Classification: NUCLEAR PROTEIN Ligands: EDO, V9Q |
 |
C-Terminal Bromodomain Of Human Brd2 With Rac-N5-((1R,5S)-3-Oxabicyclo[3.1.0]Hexan-6-Yl)-N7,3-Dimethyl-3-Phenyl-2,3-Dihydrobenzofuran-5,7-Dicarboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2021-07-28 Classification: NUCLEAR PROTEIN Ligands: V9N, EDO |
 |
C-Terminal Bromodomain Of Human Brd2 With 1-Benzyl-N5-Cyclopropyl-N3-Methyl-1H-Pyrazole-3,5-Dicarboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2021-07-28 Classification: NUCLEAR PROTEIN Ligands: EDO, VE5, PEG |
 |
C-Terminal Bromodomain Of Human Brd2 With 6-Benzyl-N2-Methyl-N4-((1S,2S)-2-Methylcyclopropyl)Pyridine-2,4-Dicarboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2021-07-21 Classification: NUCLEAR PROTEIN Ligands: UL5, EDO |
 |
C-Terminal Bromodomain Of Human Brd2 With (R)-N5-Cyclopropyl-N3-Methyl-2-Oxo-1-(1-Phenylethyl)-1,2-Dihydropyridine-3,5-Dicarboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.28 Å Release Date: 2021-07-21 Classification: NUCLEAR PROTEIN Ligands: EDO, ULH |
 |
C-Terminal Bromodomain Of Human Brd2 With Oxabicyclo(Hexan-6-Yl)-N2-Methyl-6-((S)-1-Phenylethyl)Pyridine-2,4-Dicarboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.30 Å Release Date: 2021-07-21 Classification: NUCLEAR PROTEIN Ligands: EDO, PE4, ULN |
 |
C-Terminal Bromodomain Of Human Brd2 With 6-((S)-Hydroxy(Phenyl)Methyl)-N2-Methyl-N4-((1S,2S)-2-Methylcyclopropyl)Pyridine-2,4-Dicarboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2021-07-21 Classification: NUCLEAR PROTEIN Ligands: EDO, ULK |
 |
C-Terminal Bromodomain Of Human Brd2 With (S)-N4-Cyclopropyl-N2-Methyl-6-(1-Phenylethyl)Pyridine-2,4-Dicarboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.74 Å Release Date: 2021-07-21 Classification: NUCLEAR PROTEIN Ligands: ULE, EDO |
 |
C-Terminal Bromodomain Of Human Brd2 With N4-((1R,5S,6R)-3-Oxabicyclo[3.1.0]Hexan-6-Yl)-6-((S)-Methoxy(Phenyl)Methyl)-N2-Methylpyridine-2,4-Dicarboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2021-07-21 Classification: NUCLEAR PROTEIN Ligands: EDO, ULQ |
 |
C-Terminal Bromodomain Of Human Brd2 With N-Ethyl-2-(1-Methyl-1H-1,2,3-Triazol-4-Yl)-6-(1-Phenylethyl)Isonicotinamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.73 Å Release Date: 2021-04-07 Classification: NUCLEAR PROTEIN Ligands: UME, EDO, PEG |
 |
C-Terminal Bromodomain Of Human Brd2 With 3-(2-(Benzyloxy)Phenyl)-5-Methyl-1H-1,2,4-Triazole
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2021-03-24 Classification: NUCLEAR PROTEIN Ligands: EDO, PE4, ULB |
 |
C-Terminal Bromodomain Of Human Brd2 With (S)-N-Ethyl-3-(1-Methyl-1H-1,2,3-Triazol-4-Yl)-4-(1-Phenylethoxy)Benzamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.70 Å Release Date: 2021-03-24 Classification: NUCLEAR PROTEIN Ligands: EDO, UL8 |